187 related articles for article (PubMed ID: 37999922)
1. Recent advances in point-of-care testing of COVID-19.
Lee S; Bi L; Chen H; Lin D; Mei R; Wu Y; Chen L; Joo SW; Choo J
Chem Soc Rev; 2023 Dec; 52(24):8500-8530. PubMed ID: 37999922
[TBL] [Abstract][Full Text] [Related]
2. Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution.
Kumar A; Parihar A; Panda U; Parihar DS
ACS Appl Bio Mater; 2022 May; 5(5):2046-2068. PubMed ID: 35473316
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in surface-enhanced Raman scattering-based microdevices for point-of-care diagnosis of viruses and bacteria.
Chen H; Das A; Bi L; Choi N; Moon JI; Wu Y; Park S; Choo J
Nanoscale; 2020 Nov; 12(42):21560-21570. PubMed ID: 33094771
[TBL] [Abstract][Full Text] [Related]
4. Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases.
Jain S; Nehra M; Kumar R; Dilbaghi N; Hu T; Kumar S; Kaushik A; Li CZ
Biosens Bioelectron; 2021 May; 179():113074. PubMed ID: 33596516
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Novel Lateral Flow Technologies for Detection of COVID-19.
Hsiao WW; Le TN; Pham DM; Ko HH; Chang HC; Lee CC; Sharma N; Lee CK; Chiang WH
Biosensors (Basel); 2021 Aug; 11(9):. PubMed ID: 34562885
[TBL] [Abstract][Full Text] [Related]
6. Lab-on-a-Disc for Point-of-Care Infection Diagnostics.
Sunkara V; Kumar S; Sabaté Del Río J; Kim I; Cho YK
Acc Chem Res; 2021 Oct; 54(19):3643-3655. PubMed ID: 34516092
[TBL] [Abstract][Full Text] [Related]
7. Lateral Flow Immunoassay Reader Technologies for Quantitative Point-of-Care Testing.
Park J
Sensors (Basel); 2022 Sep; 22(19):. PubMed ID: 36236497
[TBL] [Abstract][Full Text] [Related]
8. Microfluidics for COVID-19: From Current Work to Future Perspective.
Li Q; Zhou X; Wang Q; Liu W; Chen C
Biosensors (Basel); 2023 Jan; 13(2):. PubMed ID: 36831930
[TBL] [Abstract][Full Text] [Related]
9. Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT).
Dorta-Gorrín A; Navas-Méndez J; Gozalo-Margüello M; Miralles L; García-Hevia L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373381
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Quantum Dot-Based Lateral Flow Immunoassays for the Rapid, Point-of-Care Diagnosis of COVID-19.
Mousavi SM; Kalashgrani MY; Gholami A; Omidifar N; Binazadeh M; Chiang WH
Biosensors (Basel); 2023 Aug; 13(8):. PubMed ID: 37622872
[TBL] [Abstract][Full Text] [Related]
11. Microfluidic Point-of-Care Devices: New Trends and Future Prospects for eHealth Diagnostics.
Mejía-Salazar JR; Rodrigues Cruz K; Materón Vásques EM; Novais de Oliveira O
Sensors (Basel); 2020 Mar; 20(7):. PubMed ID: 32244343
[TBL] [Abstract][Full Text] [Related]
12. Visible-light and near-infrared fluorescence and surface-enhanced Raman scattering point-of-care sensing and bio-imaging: a review.
Hang Y; Boryczka J; Wu N
Chem Soc Rev; 2022 Jan; 51(1):329-375. PubMed ID: 34897302
[TBL] [Abstract][Full Text] [Related]
13. Point of care molecular and antigen detection tests for COVID-19: current status and future prospects.
Stokes W; Berenger BM; Venner AA; Deslandes V; Shaw JLV
Expert Rev Mol Diagn; 2022 Aug; 22(8):797-809. PubMed ID: 36093682
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic Point-of-Care Testing: Commercial Landscape and Future Directions.
Sachdeva S; Davis RW; Saha AK
Front Bioeng Biotechnol; 2020; 8():602659. PubMed ID: 33520958
[TBL] [Abstract][Full Text] [Related]
15. Gold nanoparticles in virus detection: Recent advances and potential considerations for SARS-CoV-2 testing development.
Wang J; Drelich AJ; Hopkins CM; Mecozzi S; Li L; Kwon G; Hong S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1754. PubMed ID: 34498423
[TBL] [Abstract][Full Text] [Related]
16. Miniaturized Raman Instruments for SERS-Based Point-of-Care Testing on Respiratory Viruses.
Ali A; Nettey-Oppong EE; Effah E; Yu CY; Muhammad R; Soomro TA; Byun KM; Choi SH
Biosensors (Basel); 2022 Aug; 12(8):. PubMed ID: 36004986
[TBL] [Abstract][Full Text] [Related]
17. Development of integrated microfluidic platform coupled with Surface-enhanced Raman Spectroscopy for diagnosis of COVID-19.
Jadhav SA; Biji P; Panthalingal MK; Murali Krishna C; Rajkumar S; Joshi DS; Sundaram N
Med Hypotheses; 2021 Jan; 146():110356. PubMed ID: 33342643
[TBL] [Abstract][Full Text] [Related]
18. Biosensing based on surface-enhanced Raman spectroscopy as an emerging/next-generation point-of-care approach for acute myocardial infarction diagnosis.
Low JSY; Thevarajah TM; Chang SW; Goh BT; Khor SM
Crit Rev Biotechnol; 2020 Dec; 40(8):1191-1209. PubMed ID: 32811205
[TBL] [Abstract][Full Text] [Related]
19. Preparing for the next pandemic: lessons learnt from the implementation of point-of-care SARS-CoV-2 testing in an emergency department.
Donnelly JA; Russell M; O'Brien G; O'Neill I; Fitzpatrick F; O'Connell K
J Clin Pathol; 2023 Sep; 76(9):642-646. PubMed ID: 37193583
[TBL] [Abstract][Full Text] [Related]
20. Smartphone-based platforms implementing microfluidic detection with image-based artificial intelligence.
Wang B; Li Y; Zhou M; Han Y; Zhang M; Gao Z; Liu Z; Chen P; Du W; Zhang X; Feng X; Liu BF
Nat Commun; 2023 Mar; 14(1):1341. PubMed ID: 36906581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
